The global mental health market is expected to be worth $560 billion by 2030, driven by an aging population and rising numbers of people with mental health disorders. By investing in mental health stocks, you can grow your portfolio while supporting companies that make and deliver treatments.
What are mental health stocks?
When you buy mental health stocks, you’re buying shares in publicly traded companies that deliver products or services related to the mental health industry. This includes creating treatments or medications, offering counselling services, producing educational materials and developing technology to assist mental healthcare professionals and clients.
How to invest in therapy stocks
Research stocks. You can check out a list of mental health stocks to watch below. Compare stock prices, past performance and company financials to decide which stocks are right for you.
Choose an investment platform. Look at fees, features and whether you can get access to the exchanges on which your stocks are trading.
Open an account and add funds. You might need to wait for your account to be verified and for your funds to hit the account before you can begin.
Find your chosen stock. Search for stocks by name (Pfizer Inc.) or ticker symbol (PFE).
Submit your order, review and buy. Buy stocks with a market order. Some platforms lets you buy fractional shares or place limit orders that trigger a buy or sell when a stock reaches your desired price.
Teladoc Health provides virtual healthcare services in the United States and internationally. Through the Teladoc, Livongo, and BetterHelp brands, it offers services for a wide range of conditions including diabetes, chronic kidney disease, cancer, congestive heart failure and mental health conditions.
Eli Lilly and Company discovers, develops and markets human pharmaceuticals worldwide. Its portfolio of products include treatments for depression, anxiety, schizophrenia, bipolar disorder, diabetes, cancer, arthritis, osteoporosis and other conditions. The company makes Prozac (fluoxetine), one of the most widely used FDA-approved antidepressants on the market.
Pfizer discovers, develops, manufactures, markets, distributes and sells a wide range of biopharmaceutical products worldwide. The company makes a number of widely used medications that treat mental health conditions including Xanax (alprazolam), Effexor (venlafaxine) and Zoloft (sertraline).
Talkspace is a New York based virtual behavior healthcare company that delivers healthcare services through encrypted web and mobile platform. The company offers treatment options for psychiatry therapy as well as adolescent, individual and couples therapy.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures and markets biopharmaceutical products worldwide including Abilify (Aripiprazole), an antipsychotic medication. It offers products for neuroscience, hematology, oncology, cardiovascular, immunology, fibrotic and covid-19 diseases.
Johnson & Johnson makes and sells healthcare products worldwide. Its brands include Johnson’s, Aveeno, Listerine, Neutrogena, Tylenol and Band-Aid. Its subsidiary, Janssen Pharmaceuticals, develops a number of treatments for mood disorders, neurodegenerative disorders and schizophrenia including Haldol (haloperidol), Risperdal (risperidone) and Invega (paliperidone).
What are the risks of investing in mental health stocks?
One of the main risks of investing in mental health stocks is that companies you don’t invest in will be quicker to come out with new treatments or technologies. For therapy stocks in companies that offer program-based treatments, there’s a risk that programs will become ineffective or that users will lose interest.
The mental health industry is growing as companies rise to meet the demands of a population increasingly challenged with mental health disorders. Investing in therapy stocks can support companies that deliver treatments or develop pharmaceuticals while diversifying your portfolio. As with all investments, there are risks to investing in mental health stocks, so be sure to carefully research companies and stock trading platforms before you buy in.
Zoe was a senior writer at Finder specialising in investment and banking, and during this time, she joined the Women in FinTech Powerlist 2022. She is currently a senior money writer at Be Clever With Your Cash. Zoe has a BA in English literature and a Diploma for Financial Advisers. She has several years of experience in writing about all things personal finance. Zoe has a particular love for spreadsheets, having also worked as a management accountant. In her spare time, you’ll find Zoe skating at her local ice rink.
A deep dive into the highlights and limitations of Robinhood.
Feedback
How likely would you be to recommend finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
Advertiser Disclosure
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
